文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

线粒体Lon蛋白酶1过表达通过减轻线粒体氧化应激缓解脓毒症小鼠心肌损伤

[Overexpression of mitochondrial Lon protease 1 alleviates myocardial injury in septic mice by attenuating mitochondrial oxidative stress].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2026-01-01
一句话结论小鼠脓毒症模型中,心肌靶向过表达LONP1可降低ROS、提高ATP与线粒体膜电位、改善LVEF与LVFS,减轻线粒体氧化应激与心肌损伤。

该研究将24只SPF级雄性C57BL/6J小鼠随机分为正常对照组、脓毒症模型组(LPS组)、腺相关病毒对照组(AAV+LPS组)和LONP1过表达组(LONP1+LPS组),每组6只。通过腹腔注射脂多糖10 mg/kg建立脓毒症心肌损伤模型,造模前3周经尾静脉注射靶向心肌、携带Lonp1基因片段的腺相关病毒(病毒滴度1×10^12 vg/mL,100 μL)实现LONP1过表达。造模后24小时,与AAV+LPS组比较,LONP1+LPS组ROS产生显著减少(荧光强度1.43±0.10 vs. 2.95±0.15),ATP、线粒体膜电位、LVEF、LVFS、LVESV显著升高,LVEDV、4-HNE、MDA、mt-ACO2含量显著降低(均P<0.05)。LPS组与AAV+LPS组上述指标差异无统计学意义。结论认为LONP1过表达可减轻脓毒症小鼠线粒体氧化应激并改善心功能。

要点

  • 在LPS 10 mg/kg腹腔注射的脓毒症心肌损伤小鼠中,心肌靶向AAV过表达LONP1使LVEF由AAV+LPS组的0.39±0.05升至0.69±0.06(P<0.05)。
  • LONP1过表达组LVFS为0.35±0.04,高于AAV+LPS组的0.18±0.03(P<0.05)。
  • LONP1过表达使ROS荧光强度由AAV+LPS组的2.95±0.15降至1.43±0.10(P<0.05)。
  • LONP1过表达使ATP由AAV+LPS组的58.03±4.54 nmol/g升至75.12±6.20 nmol/g,线粒体膜电位由0.75±0.12升至0.81±0.15(均P<0.05)。
  • LONP1过表达使MDA由AAV+LPS组的19.88±2.19 mmol/L降至13.46±1.68 mmol/L,4-HNE由6.01±0.73 ng/L降至4.70±0.55 ng/L(均P<0.05)。

适用人群与场景

  • SPF级雄性C57BL/6J小鼠,共24只,随机分为Control组、LPS组、AAV+LPS组、LONP1+LPS组,每组6只。
  • 脓毒症心肌损伤模型由腹腔注射脂多糖10 mg/kg建立;Control组腹腔注射等体积生理盐水。

诊断标准与关键阈值

  • 造模后24小时通过小鼠活动、分泌物、尿便情况,结合心脏超声和心肌组织HE染色评估脓毒症心肌损伤模型是否建立成功。
  • LONP1+LPS组在病毒转染3周后经冰冻切片和Western blotting评估Lonp1基因过表达,确认过表达成功后再造模。

处置流程与药物剂量

  • 造模前3周,Control组和LPS组经尾静脉注射等体积100 μL生理盐水作为假转染。
  • AAV+LPS组经尾静脉注射不含Lonp1基因的腺相关病毒100 μL。
  • LONP1+LPS组经尾静脉注射靶向心肌、携带Lonp1基因片段的腺相关病毒,病毒滴度1×10^12 vg/mL,体积100 μL。
  • 造模后24小时检测ROS(二氢乙锭法)、ATP与线粒体膜电位(相关试剂盒)、线粒体氧化应激指标(4-HNE、MDA、mt-ACO2)及心功能指标(LVEF、LVFS、LVESV、LVEDV)。

红旗征与不能漏的情况

  • LPS组小鼠造模后24小时出现精神萎靡、竖毛、口眼分泌物增多、脓尿和稀便。
  • LPS组小鼠LVEF和LVFS显著降低,HE染色示部分心肌纤维变性坏死、排列紊乱并伴炎性细胞浸润。

研究设计与关键结果

  • 研究类型为小鼠动物实验,24只SPF级雄性C57BL/6J小鼠随机分为4组,每组6只;处理因素为心肌靶向AAV过表达LONP1与LPS 10 mg/kg腹腔注射造模。
  • 造模后24小时,LONP1+LPS组LONP1/GAPDH为1.47±0.01,高于Control组1、LPS组1.11±0.01、AAV+LPS组1.12±0.01(均P<0.05)。
  • 与AAV+LPS组比较,LONP1+LPS组ROS荧光强度降低(1.43±0.10 vs. 2.95±0.15),ATP升高(75.12±6.20 nmol/g vs. 58.03±4.54 nmol/g),线粒体膜电位升高(0.81±0.15 vs. 0.75±0.12),均P<0.05。
  • 与AAV+LPS组比较,LONP1+LPS组LVEF升高(0.69±0.06 vs. 0.39±0.05),LVFS升高(0.35±0.04 vs. 0.18±0.03),LVESV升高(38.26±4.02 μL vs. 23.65±5.39 μL),均P<0.05。
  • 与AAV+LPS组比较,LONP1+LPS组LVEDV降低(50.26±4.02 μL vs. 62.82±5.39 μL),4-HNE降低(4.70±0.55 ng/L vs. 6.01±0.73 ng/L),MDA降低(13.46±1.68 mmol/L vs. 19.88±2.19 mmol/L),mt-ACO2降低(528.26±72.41 U/g vs. 1 286.82±151.28 U/g),均P<0.05。
  • LPS组与AAV+LPS组上述指标差异无统计学意义。
  • 与Control组比较,LPS组和AAV+LPS组ROS产生显著增加,ATP、线粒体膜电位、LVEF、LVFS、LVESV显著降低,LVEDV、4-HNE、MDA、mt-ACO2含量显著增加。
  • 冰冻切片荧光显微镜下,LONP1+LPS组可见绿色荧光蛋白信号集中于心肌细胞胞质,沿心肌纤维长轴呈连续条纹状分布,荧光强度明显高于周围间质。

证据类型、等级与局限

  • 证据类型:小鼠动物实验(SPF级雄性C57BL/6J小鼠,每组6只)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该研究为小鼠动物实验,结果提示心肌靶向过表达LONP1可降低脓毒症小鼠ROS产生、促进ATP生成、增强线粒体膜电位、减轻线粒体氧化应激,从而改善心功能;原文未据此给出临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the effects of mitochondrial Lon protease 1 (LONP1) overexpression on mitochondrial oxidative stress in a mouse model of septic myocardial injury.

METHODS: Twenty-four SPF-grade male C57BL/6J mice were randomly divided into a normal control group (Control group), a sepsis model group (LPS group), an adeno-associated virus control group (AAV+LPS group), and a LONP1 overexpression group (LONP1+LPS group), with 6 mice in each group. A septic myocardial injury model was established by intraperitoneal injection of lipopolysaccharide (LPS) at 10 mg/kg; the Control group was intraperitoneally injected with an equal volume of normal saline. Three weeks before modeling, the Control group and LPS group were sham-transfected via tail vein injection with an equal volume (100 μL) of normal saline; the AAV+LPS group was injected with adeno-associated virus (AAV) without the Lonp1 gene (100 μL) via tail vein; the LONP1+LPS group was injected with AAV targeting the myocardium and carrying the Lonp1 gene fragment (viral titer: 1×1012 vg/mL, 100 μL) via tail vein. In the LONP1+LPS group, Lonp1 gene overexpression was evaluated by frozen section and Western blotting 3 weeks after viral transfection, and modeling was performed after successful overexpression was confirmed. Twenty-four hours after modeling, the establishment of the septic myocardial injury model was assessed by mouse activity, secretions, urine and feces, combined with cardiac echocardiography, and hematoxylin-eosin (HE) staining of myocardial tissue; reactive oxygen species (ROS) production was detected by dihydroethidium (DHE) method; adenosine triphosphate (ATP) production and mitochondrial membrane potential changes were detected by relevant kits. Changes in mitochondrial oxidative stress indicators [4-hydroxynonenal (4-HNE), malondialdehyde (MDA), mitochondrial aconitase 2 (mt-ACO2)] and cardiac function indicators [left ventricular ejection fraction (LVEF), left ventricular fractional shortening (LVFS), left ventricular end-systolic volume (LVESV), left ventricular end-diastolic volume (LVEDV)] were also evaluated.

RESULTS: Twenty-four hours after modeling, compared with the Control group, mice in the LPS group exhibited lethargy, piloerection, increased oral and ocular secretions, pyuria, and loose stools; LVEF and LVFS were significantly decreased; HE staining showed degeneration and necrosis of some myocardial fibers in the LPS group, with disordered arrangement and inflammatory cell infiltration. Under fluorescence microscopy after frozen section, successful viral transfection was observed in the LONP1+LPS group; Western blotting showed that, compared with the Control group, LPS group, and AAV+LPS group, protein expression of LONP1 was significantly increased in the LONP1+LPS group (LONP1/GAPDH: 1.47±0.01 vs. 1, 1.11±0.01, 1.12±0.01, all P<0.05). Under fluorescence microscopy, green fluorescent protein (GFP) signals were concentrated in the cytoplasm of cardiomyocytes, showing continuous and striped distribution along the long axis of myocardial fibers, with fluorescence intensity significantly higher than that in the surrounding interstitium, indicating widespread infection of AAV9-cardiac troponin T (cTnT)-LONP1-GFP in myocardial tissue and enrichment of expression products in cardiomyocytes. Compared with the Control group, ROS production was significantly increased in the LPS group and AAV+LPS group; ATP, mitochondrial membrane potential, LVEF, LVFS, and LVESV were significantly decreased; LVEDV, 4-HNE, MDA, and mt-ACO2 contents were significantly increased. Compared with the AAV+LPS group, ROS production was significantly decreased in the LONP1+LPS group (fluorescence intensity: 1.43±0.10 vs. 2.95±0.15); ATP, mitochondrial membrane potential, LVEF, LVFS, and LVESV were significantly increased [ATP (nmol/g): 75.12±6.20 vs. 58.03±4.54, mitochondrial membrane potential: 0.81±0.15 vs. 0.75±0.12, LVEF: 0.69±0.06 vs. 0.39±0.05, LVFS: 0.35±0.04 vs. 0.18±0.03, LVESV (μL): 38.26±4.02 vs. 23.65±5.39, all P<0.05]; LVEDV, 4-HNE, MDA, and mt-ACO2 contents were significantly decreased [LVEDV (μL): 50.26±4.02 vs. 62.82±5.39, 4-HNE (ng/L): 4.70±0.55 vs. 6.01±0.73, MDA (mmol/L): 13.46±1.68 vs. 19.88±2.19, mt-ACO2 (U/g): 528.26±72.41 vs. 1 286.82±151.28, all P<0.05]. No statistically significant differences were observed in the aforementioned indicators between the LPS and AAV+LPS groups.

CONCLUSIONS: LONP1 overexpression reduces ROS production, promote ATP generation, enhance mitochondrial membrane potential, and alleviate mitochondrial oxidative stress in septic mice, thereby improving cardiac function.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Luo X, Zhao S, Geng Z, et al. [Overexpression of mitochondrial Lon protease 1 alleviates myocardial injury in septic mice by attenuating mitochondrial oxidative stress]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 41958129. doi:10.3760/cma.j.cn121430-20250224-00103

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。